Cargando…

Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient

Immune reconstitution syndrome (IRIS) is a state of unusual hyperinflammatory response against latent infections which occurs after CD4 cell count improvement and as a consequence of immune response once highly active antiretroviral therapy for HIV is introduced. Leishmania parasites and varicella z...

Descripción completa

Detalles Bibliográficos
Autores principales: Muço, Ermira, Karruli, Arta, Hoxha, Neada, Hoxhaj, Alma, Kokici, Majlinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938089/
https://www.ncbi.nlm.nih.gov/pubmed/35321085
http://dx.doi.org/10.1155/2022/2784898
_version_ 1784672478262460416
author Muço, Ermira
Karruli, Arta
Hoxha, Neada
Hoxhaj, Alma
Kokici, Majlinda
author_facet Muço, Ermira
Karruli, Arta
Hoxha, Neada
Hoxhaj, Alma
Kokici, Majlinda
author_sort Muço, Ermira
collection PubMed
description Immune reconstitution syndrome (IRIS) is a state of unusual hyperinflammatory response against latent infections which occurs after CD4 cell count improvement and as a consequence of immune response once highly active antiretroviral therapy for HIV is introduced. Leishmania parasites and varicella zoster virus (VZV) may be a manifestation of IRIS, but few data exist in literature in particular regarding Leishmania parasites. Case Presentation. A 47-year-old man was admitted to our hospital with fever. He was diagnosed with HIV infection and was a late presenter according to CD4+ count of 98 cells/mm(3)/9.5% and baseline illness (chronic diarrhea, weight loss, and oral candidiasis). The patient started highly active antiretroviral therapy (abacavir plus lamivudine plus efavirenz). Clinical symptoms improved and CD4+ increased to 22%, 374 cells/mm(3). After 88 days, he presented with a 17-day history of high fever, sweat, fatigue, further weight loss, and lethargy. According to clinical image findings and hematochemical parameters, the patient was diagnosed with visceral leishmaniasis. He improved under treatment with liposomal amphotericin B. He presented again, 105 days after with disseminated herpes zoster infection. CD4+ count was 28.5%, 455 cell/mm(3). The patient started treatment with acyclovir for 10 days. Four weeks later, he had no skin elements. At present, the patient continues HAART and is under regular monitoring. Conclusions. Early diagnosis of IRIS-associated diseases and treatment were fundamental in the patient's prognosis. Our patient presented with two different components of IRIS in two different time frames, confirming IRIS to be a broad-spectrum disease, heterogeneous and unique for each patient. A close monitoring during ART initiation, in particular in late presenters, is important in preventing IRIS. In case of IRIS development, a detailed investigation of rare associated diseases not only common ones is of great importance for the management and the prognosis of these patients.
format Online
Article
Text
id pubmed-8938089
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-89380892022-03-22 Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient Muço, Ermira Karruli, Arta Hoxha, Neada Hoxhaj, Alma Kokici, Majlinda Case Rep Infect Dis Case Report Immune reconstitution syndrome (IRIS) is a state of unusual hyperinflammatory response against latent infections which occurs after CD4 cell count improvement and as a consequence of immune response once highly active antiretroviral therapy for HIV is introduced. Leishmania parasites and varicella zoster virus (VZV) may be a manifestation of IRIS, but few data exist in literature in particular regarding Leishmania parasites. Case Presentation. A 47-year-old man was admitted to our hospital with fever. He was diagnosed with HIV infection and was a late presenter according to CD4+ count of 98 cells/mm(3)/9.5% and baseline illness (chronic diarrhea, weight loss, and oral candidiasis). The patient started highly active antiretroviral therapy (abacavir plus lamivudine plus efavirenz). Clinical symptoms improved and CD4+ increased to 22%, 374 cells/mm(3). After 88 days, he presented with a 17-day history of high fever, sweat, fatigue, further weight loss, and lethargy. According to clinical image findings and hematochemical parameters, the patient was diagnosed with visceral leishmaniasis. He improved under treatment with liposomal amphotericin B. He presented again, 105 days after with disseminated herpes zoster infection. CD4+ count was 28.5%, 455 cell/mm(3). The patient started treatment with acyclovir for 10 days. Four weeks later, he had no skin elements. At present, the patient continues HAART and is under regular monitoring. Conclusions. Early diagnosis of IRIS-associated diseases and treatment were fundamental in the patient's prognosis. Our patient presented with two different components of IRIS in two different time frames, confirming IRIS to be a broad-spectrum disease, heterogeneous and unique for each patient. A close monitoring during ART initiation, in particular in late presenters, is important in preventing IRIS. In case of IRIS development, a detailed investigation of rare associated diseases not only common ones is of great importance for the management and the prognosis of these patients. Hindawi 2022-03-14 /pmc/articles/PMC8938089/ /pubmed/35321085 http://dx.doi.org/10.1155/2022/2784898 Text en Copyright © 2022 Ermira Muço et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Muço, Ermira
Karruli, Arta
Hoxha, Neada
Hoxhaj, Alma
Kokici, Majlinda
Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient
title Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient
title_full Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient
title_fullStr Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient
title_full_unstemmed Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient
title_short Visceral Leishmaniasis and Herpes Zoster as a Component of Syndrome of Immune Reconstitution Inflammatory Syndrome in an HIV-Positive Patient
title_sort visceral leishmaniasis and herpes zoster as a component of syndrome of immune reconstitution inflammatory syndrome in an hiv-positive patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938089/
https://www.ncbi.nlm.nih.gov/pubmed/35321085
http://dx.doi.org/10.1155/2022/2784898
work_keys_str_mv AT mucoermira visceralleishmaniasisandherpeszosterasacomponentofsyndromeofimmunereconstitutioninflammatorysyndromeinanhivpositivepatient
AT karruliarta visceralleishmaniasisandherpeszosterasacomponentofsyndromeofimmunereconstitutioninflammatorysyndromeinanhivpositivepatient
AT hoxhaneada visceralleishmaniasisandherpeszosterasacomponentofsyndromeofimmunereconstitutioninflammatorysyndromeinanhivpositivepatient
AT hoxhajalma visceralleishmaniasisandherpeszosterasacomponentofsyndromeofimmunereconstitutioninflammatorysyndromeinanhivpositivepatient
AT kokicimajlinda visceralleishmaniasisandherpeszosterasacomponentofsyndromeofimmunereconstitutioninflammatorysyndromeinanhivpositivepatient